Competitive Analysis of Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market

Key Players

• Amgen
• BlackRock
• B BRAUN MELSUNGEN AG RDI project
• Baxter International
• Beckman Coulter
• ChemoCentryx Inc
• Dimerix Ltd
• Medtronic plc
• Mylan N.V
• Novartis
• The Vanguard Group
• Roche
• Travere Therapeutics
• Vertex Pharmaceuticals Incorporated